Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:00 PM
Ignite Modification Date:
2025-12-24 @ 2:00 PM
NCT ID:
NCT00306995
Eligibility Criteria:
Inclusion criteria:
* Subjects who the investigator believes that they can and will comply with the requirements of the protocol
* A male or female aged over 60 years at the time of vaccination.
* Written informed consent obtained from the subject.
Exclusion criteria:
* Use of any investigational or non-registered product (drug or vaccine) other than the study vaccine(s) within 30 days preceding the administration of the study vaccine, or planned use during the study period.
* Participation in an earlier study with a candidate pandemic H9N2 vaccine.
* Acute disease at the time of enrolment.
* Acute clinically significant pulmonary, cardiovascular, hepatic or renal functional abnormality
* History of allergic disease or reactions likely to be exacerbated by any component of the vaccine.
* Drug and/or alcohol dependency.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
60 Years
Study:
NCT00306995
Study Brief:
Protocol Section:
NCT00306995